Story
DiaSorin Stock Slides After UBS Downgrade to 'Sell' on Competition Fears

Shares of Italian diagnostics company DiaSorin S.p.A. (BIT: DIA) fell 3.8% to €73.68 in Tuesday trading after analysts at UBS downgraded the stock to "Sell" from a previous "Neutral" rating, expressing caution over the company's growth prospects.
UBS Cites Competitive Headwinds
The downgrade was accompanied by a nearly 17% cut to UBS's price target for DiaSorin, now set at €55. In a note to clients, the investment bank highlighted several key concerns that challenge consensus expectations for sustained, above-market growth.
Key drivers for the more bearish outlook include:
- Growing competition and policy headwinds in China for DiaSorin's core immunodiagnostics business.
- Skepticism that the company's new Liaison Nes molecular diagnostics platform can capture enough market share to meet current expectations.
- A valuation premium of 15% over its peer, bioMérieux, which UBS views as unjustified.
AdUBS analysts now estimate that DiaSorin's 2026 earnings before interest and taxes (EBIT) will come in 4% to 6% below the market consensus, reflecting these challenges.
Market Impact and Context
The sell-off pushed DiaSorin's stock further below its 52-week high of €92.32, underscoring a significant de-rating for the company over the past year. The pressure on the stock was company-specific, as there was no notable weakness in its home benchmark, the Italian FTSE MIB, to drive the decline.
The broader sentiment for the European healthcare diagnostics sector has been cautious, according to the report, amid macroeconomic uncertainty and pressures on healthcare spending. The UBS note adds to investor concerns that have lingered since the company's July earnings update.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.

Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.

Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.

DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.